Last reviewed · How we verify

5-alpha reductase inhibitor

Ain Shams University · FDA-approved active Small molecule Quality 2/100

5-alpha reductase inhibitor is a Small molecule drug developed by Ain Shams University. It is currently FDA-approved. Also known as: Finasterid®.

At a glance

Generic name5-alpha reductase inhibitor
Also known asFinasterid®
SponsorAin Shams University
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about 5-alpha reductase inhibitor

What is 5-alpha reductase inhibitor?

5-alpha reductase inhibitor is a Small molecule drug developed by Ain Shams University.

Who makes 5-alpha reductase inhibitor?

5-alpha reductase inhibitor is developed and marketed by Ain Shams University (see full Ain Shams University pipeline at /company/ain-shams-university).

Is 5-alpha reductase inhibitor also known as anything else?

5-alpha reductase inhibitor is also known as Finasterid®.

What development phase is 5-alpha reductase inhibitor in?

5-alpha reductase inhibitor is FDA-approved (marketed).

Related